Caspofungin Derivative Oxidation Purification Impurity Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing caspofungin suffer from low oral bioavailability and the challenge of controlling impurities, particularly a previously unreported by-product that appears during fermentation, which complicates purification and stability.
Innovation Solution
The development of caspofungin hydroxylamine, a compound with potential antifungal activity, is introduced, along with a method involving oxidation of caspofungin using peroxyacids and chromatographic purification to isolate and characterize this compound, enhancing impurity control and providing a new pharmaceutical form for antifungal treatment.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If fermentation process is used to produce caspofungin, then antifungal activity is achieved, but impurities are formed that complicate purification
Solution Approach 1:
The patent applies preliminary action by developing analytical methods and purification protocols before the impurity becomes a critical problem. The shoulder peak phenomenon is identified and characterized in advance, allowing for proactive purification strategy development rather than reactive problem-solving after impurity formation
Solution Approach 2:
The patent employs parameter changes by optimizing fermentation conditions, purification parameters, and analytical method parameters to control impurity formation. By adjusting process parameters and purification conditions, the patent achieves better separation of caspofungin from impurities while maintaining antifungal activity
2Reliability
If caspofungin is administered intravenously to achieve therapeutic effect, then antifungal treatment is effective, but oral bioavailability is low
Solution Approach 1:
The patent applies parameter changes by modifying the chemical structure of caspofungin through derivatization. By changing molecular parameters such as adding solubilizing groups or modifying functional groups, the patent aims to improve oral bioavailability while preserving the core antifungal activity against Candida and Aspergillus
3Manufacturing precision
If fermentation process is optimized to prevent impurity formation, then purification is simplified, but process complexity increases
Solution Approach 1:
The patent applies self-service by developing self-monitoring analytical methods that automatically detect and quantify impurities. The analytical protocols enable the process to monitor itself, providing real-time feedback on impurity formation without requiring complex external intervention or manual analysis
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach improves the analysis and purification of caspofungin, identifies and isolates a previously unknown impurity, and offers a new antifungal compound with improved stability and bioavailability, addressing the limitations of existing caspofungin production and treatment options.
Implementation Method 1
The development of caspofungin hydroxylamine, a compound with potential antifungal activity, is introduced, along with a method involving oxidation of caspofungin using peroxyacids
Implementation Method 2
chromatographic purification to isolate and characterize this compound
Data Source
Figure 1
Figure 2
Figure 3
AI summary
The present invention relates to a novel cyclohexapeptide, to a method for the preparation of said cyclohexapeptide and to the use of said cyclohexapeptide.